Impact Factor
3.24
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.69
484 total citations
h5-index
26
h5 depth signal
Cited share
67.4%
126 of 187
Total citations
484
Citation footprint
Metric signal
1.89
External metric anchor
Self-citation
0.6%
3 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
France
272
China
148
Iran
72
Brazil
60
India
55
Citing Fields of Research
Pharmacology & Toxicology
112
Anesthetic & Pain Medicine
88
Cardiology
74
Substance Abuse
68
Diabetes
66
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,307
Articles tracked across the journal lifetime
Indexed publication set
187
126 cited publications
Last 12 months
60
5.0 publications/month
Open access share
46.7%
28 OA publications in the last year
Leading citing country
France
272 citing publications
Leading citing field
Pharmacology & Toxicology
112 citing publications
Latest tracked publication
1 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1987-
v1n1, 1987-
Active Coverage
Research Focus & Classification
Indexed Subjects
Substance Abuse
Cardiology
Anesthetic & Pain Medicine
Pharmacology & Toxicology
Immunology
Neurodegenerative Disorders
Oncology
Issuing & Sponsoring Bodies
Contributor
Association des pharmacologistes (France)
Contributor
Société française de pharmacologie
Contributor
Société française de pharmacologie et de thérapeutique
Contributor
Federation of the European Pharmacological Societies
Contributor
European Society of Cardiology. Working Group on Cardiovascular Pharmacology and Drug Therapy
Broad Categories
Pharmacology
Cardiology
Molecular Pharmacology
Musculoskeletal Disorders
Neurodegenerative Disorders
Antibiotic & Antibacterial Agents
Cancer, Autophagy & Apoptosis
Anesthetic & Pain Medicine
MeSH Descriptors
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/fcp.70065
Open DOI
Issue Information
02
DOI 10.1111/fcp.70112
Open DOI
Vitamin D Supplementation and Mortality in the Elderly: A Review of a Meta‐Analysis of Randomized Controlled Trials Using the REB Method
Background: The results of randomized controlled trials (RCTs) regarding the effect of vitamin D supplementation on mortality reduction are conflicting. Objective: The aim of this study was to assess the level of evidence through a sensi...
03
DOI 10.1111/fcp.70099
Open DOI
Discussed Posters
04
DOI 10.1111/fcp.70098
Open DOI
Oral Communication
05
DOI 10.1111/fcp.70106
Open DOI
Issue Information
06
DOI 10.1111/fcp.70101
Open DOI
Author Index
07
08
DOI 10.1111/fcp.70097
Open DOI
Drug News and Therapeutic News
09
DOI 10.1111/fcp.70111
Open DOI
Exploring the Molecular Mechanisms of SB216763 in the Therapeutic Intervention of Pulmonary Fibrosis Based on Macrophage Functional Plasticity
Background: SB216763 has demonstrated efficacy in treating pulmonary fibrosis in animal models, but its underlying mechanisms remain poorly understood. This study used network pharmacology, molecular docking, and molecular dynamics simul...
10
DOI 10.1111/fcp.70110
Open DOI
Redefining Regulatory Proof: The End of the Two‐Trial Paradigm
The recent decision to establish a single pivotal trial as the default evidentiary standard for Food and Drug Administration (FDA) approval marks a substantive shift in the architecture of regulatory proof. This marks a shift from replic...
Bibliographical & Catalog Notes
Print issues ceased with v. 29, no. 6 (Dec. 2015).
Supplements accompany some issues.
Also issued online.
Published under the auspices of: The Association des pharmacologistes (later: Société française de pharmacologie; and then: Societe francaise de pharmacologie et de therapeutique), 1987-; and also of: Federation of the European Pharmacological Societies, <2001->
Vol. 1, no. 1 (1987)19900523 Notice not published Printed on acid-free paper